Health Condition 1: C541- Malignant neoplasm of endometrium Health Condition 2: O- Medical and Surgical
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Epithelial endometrial cancer- endometrioid, papillary serous, clear-cell, squamous, mucinous, undifferentiated, carcino-sarcoma Surgery as primary definitive treatment modality
Exclusion criteria
Exclusion criteria: Double primaries Uterine sarcomas Patients receiving neo-adjuvant chemotherapy/radiotherapy Previous h/o radiation to the pelvis Secondary uterine cancers Residual tumour History of tubal ligation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To analyse the rate of tumour cells dissemination during hysterectomy after fallopian tube and cervical os occlusion compared to non- interventional arm with the help of peritoneal and vaginal cytology in endometrial cancer. Timepoint: 15 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Rate of positive peritoneal cytology (PPC) in endometrial cancer. Rate of abnormal endometrial cells detection on PAPs in endometrial cancer. Co-relation between PPC and other risk factors (histology, grade, LVSI, degree of myometrial infiltration) in endometrial cancer. Timepoint: 1 month | — |
Countries
India
Contacts
Dr. B. Barooah Cancer Institute